BCR/ABL1 | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,460 results for “BCR/ABL1”

Asciminib(Scemblix)

Conditions: Chronic Phase Chronic Myeloid Leukemia

C₂₀H₁₈ClF₂N₅O₃

BCR-ABL(Theseus)

BCR-Abl inhibitor(Nanjing Sanhome Pharmaceutical)

ACTB-1011

Bcr-Abl kinase inhibitors (Pfizer Global Research and Development)

BCR-ABL tyrosine kinase inhibitor (Chronic myelocytic leukemia/Acute lymphoblastic leukemia)

anti-BCR CAR T-cell therapy (XCART, B cell lymphoma)

AB1

CART-AML1

RGI-Ab01

Page 1 of 49